![Fenel Eloi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Fenel Eloi currently works as a Director at Cellia Science, Inc.
Actieve functies van Fenel Eloi
Bedrijven | Functie | Begin |
---|---|---|
Cellia Science, Inc.
![]() Cellia Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Cellia Science, Inc.
![]() Cellia Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cellia Science, Inc. develops and commercializes blood cell analyzers that provide rapid, actionable blood cell counts at the point of care. The company was founded in 2021 and is based in Fayetteville, AR. Cellia Science's lead device provides neutrophil and platelet counts for chemotherapy patients at risk of neutropenia and thrombocytopenia, using label-free deep-UV imaging technology exclusively licensed from a third party. The technology will be applied to additional diseases with significant unmet need in the future. Kelly Mabry has been the CEO of the company since 2022. | Commercial Services |